METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD), DIABETES, AND CARDIOVASCULAR DISEASE: ASSOCIATIONS WITH FRUCTOSE METABOLISM AND GUT MICROBIOTA